TapImmune Inc. | Mutual Funds
Mutual Funds that own TapImmune Inc.
Vanguard Total Stock Market Index Fund
170,601
1.25%
22,692
0%
07/31/2018
Driehaus Micro Cap Growth Fund
124,561
0.91%
124,561
0.22%
06/30/2018
Vanguard Extended Market Index Fund
31,905
0.23%
13,211
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
30,670
0.23%
0
0%
07/31/2018
iShares Micro Cap ETF
19,671
0.14%
0
0.02%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
13,292
0.1%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
8,155
0.06%
0
0%
07/31/2018
Vanguard Balanced Index Fund
7,309
0.05%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
4,601
0.03%
0
0%
07/31/2018
2,458
0.02%
0
0.07%
09/05/2018
| Address |
5 West Forsyth Street
Jacksonville Florida 32202
United States
|
|
Employees
|
- |
| Website |
http://www.tapimmune.com |
| Updated |
09/14/2018 |
| TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL. |
